✓
Open
13 Nov 2024
✓
Close
18 Nov 2024
3
Allotment
—
✓
Listing
Fri, Nov 22, 2024
Price Band
₹58 to ₹61
Issue Size
48,10,000 shares (agg. up to ₹29 Cr)
Lot Size
2,000 Shares
Listing Date
Fri, Nov 22, 2024
Latest GMP
₹5
Est. Gain
8.2%
✦ AI Insight
GMP Trend
22-11-2024₹5Est. ₹66+8.2%
21-11-2024₹5Est. ₹66+8.2%
20-11-2024₹6Est. ₹67+9.84%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 138.06x |
Restated Financials (₹ Cr.)
| Period Ended | 31 May 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 74.77 | 74.14 | 58.72 | 36.84 |
| Total Income | 10.54 | 53.87 | 39.62 | 44.98 |
| Profit After Tax | 1.31 | 3.03 | 1.84 | 3.35 |
| NET Worth | 26.19 | 24.88 | 18.20 | 16.38 |
| Reserves and Surplus | 12.86 | 11.56 | 12.30 | 10.47 |
| Total Borrowing | 31.56 | 30.78 | 29.23 | 12.24 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Medicamen Organics Ltd. | SME | ₹10.54 Cr | ₹34 | 30.53 | ₹144.70 | +325.59% | ₹22.90 (-0.43%) |
| Quest Laboratories Ltd. | SME | ₹43.16 Cr | ₹97 | 23.03 | ₹147.35 | +51.91% | ₹94.50 (-2.53%) |
| Zenith Drugs Ltd. | SME | ₹40.68 Cr | ₹79 | 18.4 | ₹105.15 | +33.10% | ₹51.00 (+1.80%) |
| Akums Drugs & Pharmaceuticals Ltd. | Mainboard | ₹1,856.74 Cr | ₹679 | null | ₹796.25 | +17.27% | ₹664.95 (-2.60%) |
| Emcure Pharmaceuticals Ltd. | Mainboard | ₹1,952.03 Cr | ₹1008 | 34.55 | ₹1,359.15 | +34.84% | ₹1,783.20 (-1.07%) |
| Innova Captab Ltd. | Mainboard | ₹570.00 Cr | ₹448 | 31.64 | ₹541.40 | +20.85% | ₹962.70 (-4.76%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use; | 6.08 |
| 2 | Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections; | 1.24 |
| 3 | Prepayment or repayment of all or a portion of certain loans availed by the Company; and | 12.00 |
| 4 | General Corporate Purposes | 6.00 |
About Onyx Biotec IPO
Incorporated in May 2005, Onyx Biotec Limited is a pharmaceutical company providing sterile water for injections. The company currently manufactures Sterile Water for Injections and serves as a pharmaceutical contract manufacturer, offering a comprehensive range of Dry Powder Injections and Dry Syrups for both the Indian and overseas markets. The company has two manufacturing units in Solan, Himachal Pradesh. Unit I has a daily production capacity of 638,889 units of Sterile Water for Injections, while Unit II produces 40,000 units of dry powder injections and 26,667 units of dry syrup per day in a single shift. The company clientele includes Hetero Healthcare Limited, Mankind Pharma Limited, Sun Pharmaceutical Industries Limited, Aristo Pharmaceuticals Private Limited, Macleods Pharmaceuticals Limited, Mapra Laboratories Private Limited, Axa Parenterals Limited, FDC Limited, Zuventus Healthcare Limited, Akums Drugs and Pharmaceuticals Limited, Reliance Life Sciences Limited, among others. As of May 31, 2024, the company had a client base of more than 100 Indian and multinational pharmaceutical companies. The company has received certificates for the management system, ISO 9001:201
Contact Details
Onyx Biotec Ltd. AddressBir PlassiNear SainimajraroparNalagarh RoadSolan, Himachal Pradesh, 174101+91 172 265 6384generalinfo@onyxbiotec.comVisit Website